Towle & Co’s CVS Health CVS Stock Holding History

Towle & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,950	Closed	-$299K	–	73
2022 Q1	$299K	Buy	+2,950	New	+$310K	0.04%	62

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Towle & Co's CVS Position: Q2 2022 in Review

Towle & Co sold out of CVS Health (CVS) in Q2 2022, closing a stake of 2,950 shares — an estimated $299K sold.

Towle & Co first reported a position in CVS in Q1 2022 and held it in 1 quarter. The position peaked at $299K in Q1 2022. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Towle & Co reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
Towle & Co sold 2,950 CVS Health shares in Q2 2022, an estimated $299K.
Towle & Co first reported a position in CVS Health in Q1 2022 and held it in 1 quarter.
Towle & Co's CVS Health position peaked at $299K in Q1 2022.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Towle & Co's 13F filing for Q2 2022, filed 15 Aug 2022.